Guangjie Zhao

No.12 Wulumuqi Middle Road
Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

STING is crucial for the survival of RUNX1::RUNX1T1 leukemia cells.

STING is crucial for the survival of RUNX1::RUNX1T1 leukemia cells.

Journal: Leukemia

Published: April 09, 2024

CircZBTB46 predicts poor prognosis and promotes disease progression of myelodysplastic syndromes and acute myeloid leukemia.

CircZBTB46 predicts poor prognosis and promotes disease progression of myelodysplastic syndromes and acute myeloid leukemia.

Journal: Clinical and experimental medicine

Published: March 15, 2023

Effect of iron supplementation on platelet count in adult patients with iron deficiency anemia.

Effect of iron supplementation on platelet count in adult patients with iron deficiency anemia.

Journal: Platelets

Published: September 02, 2022

ABAT gene expression associated with the sensitivity of hypomethylating agents in myelodysplastic syndrome through CXCR4/mTOR signaling.

ABAT gene expression associated with the sensitivity of hypomethylating agents in myelodysplastic syndrome through CXCR4/mTOR signaling.

Journal: Cell death discovery

Published: April 21, 2022

Resistance to Hypomethylating Agents in Myelodysplastic Syndrome and Acute Myeloid Leukemia From Clinical Data and Molecular Mechanism.

Resistance to Hypomethylating Agents in Myelodysplastic Syndrome and Acute Myeloid Leukemia From Clinical Data and Molecular Mechanism.

Journal: Frontiers in oncology

Published: May 06, 2021

The Efficacy and Safety of Vitamin C for Iron Supplementation in Adult Patients With Iron Deficiency Anemia: A Randomized Clinical Trial.

The Efficacy and Safety of Vitamin C for Iron Supplementation in Adult Patients With Iron Deficiency Anemia: A Randomized Clinical Trial.

Journal: JAMA network open

Published: November 02, 2020

LOC101928834, a novel lncRNA in Wnt/β-catenin signaling pathway, promotes cell proliferation and predicts poor clinical outcome in myelodysplastic syndromes.

LOC101928834, a novel lncRNA in Wnt/β-catenin signaling pathway, promotes cell proliferation and predicts poor clinical outcome in myelodysplastic syndromes.

Journal: Clinical science (London, England : 1979)

Published: April 16, 2020

[Corrigendum] Role of 4‑aminobutyrate aminotransferase (ABAT) and the lncRNA co‑expression network in the development of myelodysplastic syndrome.

[Corrigendum] Role of 4‑aminobutyrate aminotransferase (ABAT) and the lncRNA co‑expression network in the development of myelodysplastic syndrome.

Journal: Oncology reports

Published: October 11, 2018

Role of 4‑aminobutyrate aminotransferase (ABAT) and the lncRNA co‑expression network in the development of myelodysplastic syndrome.

Role of 4‑aminobutyrate aminotransferase (ABAT) and the lncRNA co‑expression network in the development of myelodysplastic syndrome.

Journal: Oncology reports

Published: October 11, 2018

High methylation of the 4-aminobutyrate aminotransferase gene predicts a poor prognosis in patients with myelodysplastic syndrome.

High methylation of the 4-aminobutyrate aminotransferase gene predicts a poor prognosis in patients with myelodysplastic syndrome.

Journal: International journal of oncology

Published: July 17, 2018

Clinical diagnosis of adult patients with acute megakaryocytic leukemia.

Clinical diagnosis of adult patients with acute megakaryocytic leukemia.

Journal: Oncology letters

Published: November 08, 2017

Synergistic inhibitory effects of deferasirox in combination with decitabine on leukemia cell lines SKM-1, THP-1, and K-562.

Synergistic inhibitory effects of deferasirox in combination with decitabine on leukemia cell lines SKM-1, THP-1, and K-562.

Journal: Oncotarget

Published: June 19, 2016

Showing 1-12 of 12

Last Updated: 09/26/2026